Our Team

Experienced leaders in pharmaceutical development, dermatology, and clinical science.

DR

Dr. Richard Bergstrom PhD

Strategic Science Advisor

Dr. Bergstrom brings extensive experience in pharmaceutical development and strategic science advisory roles. His expertise in dermatology and clinical development helps guide Celfex's research programs.

Fv

Fredrik von Kieseritzky PhD

Development Advisor

Dr. von Kieseritzky is a seasoned pharmaceutical development advisor with deep expertise in formulation science and drug delivery systems. He supports Celfex's product development strategy.

DA

Dr. Adel El Messiry PhD

Chairman, MHG Management GmbH

Dr. El Messiry serves as Chairman of MHG Management GmbH, Celfex's parent company. He provides strategic oversight and leadership to the Celfex clinical development programs.

JS

John Schnell

CEO, MHG Management GmbH

John Schnell leads MHG Management GmbH as CEO, bringing business development and operational expertise to support Celfex's growth and commercialization strategy.

Our Parent Company

MHG Management GmbH

MHG Management GmbH is a diversified management and investment company that provides strategic oversight, resources, and operational expertise to its portfolio companies. As the parent company of Celfex AB, MHG supports the development and commercialization of Celfex's dermatology pipeline, including the topical Fexofenadine program for Atopic Dermatitis.